News and Articles

Stories of Hope

Follow A Race Against Blindness research funding, inherited retinal disease developments, community stories, grant announcements, and updates from families racing toward sight-saving treatments.

Grant history

Hope, Funded

Every dollar below has been paid out to research, made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.

$6.1M

total research funding, fully paid out · as of November 2026

  1. 2024

    $3M awarded

    October
    $1M
    December
    $2M — announced Feb 2025

    To fund the preclinical development and regulatory preparation of AXV-101, a gene therapy for Bardet-Biedl Syndrome type 1 (BBS1), advancing the program toward its first human clinical trial.

  2. 2025

    $2.1M awarded

    September
    $1M
    December
    $1.1M — announced Jan 2026

    To support clinical development of the first-in-human trial, including trial preparation and regulatory progress following clinical trial clearance, and to close the remaining funding gap required to launch the AXV-101 clinical trial, enabling the study to begin in early 2026.

  3. 2026

    $1M awarded

    June
    $1M

    Through a grant to the Foundation Fighting Blindness, to fund early-stage gene therapy research with Dr. Thomas Mendel and gene-agnostic therapy (NACA) aimed at slowing vision loss in RP. A matched donor brought in an additional $775,000, bringing the total impact of that grant round to $1.55M.

Latest posts

Fundraiser stories

  1. Behind the scenes

    Founder Spotlight: Dr. Steve Johnston, MD, MBA

    Founder Spotlight: Steve Johnston, MD, MBA Steve donated the very first van that launched our sweepstakes, and he continues to lead with dedication as a father, physician, and entrepreneur. Still working full-time as a radiologist and taking no salary, Steve devotes his days to building A Race Against Blindness and driving hope for families affected by Bardet-Biedl Syndrome.

    Read more
  2. Behind the scenes

    Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness

    Have questions about A Race Against Blindness or our fundraiser sweepstakes? This hub page gathers all five articles from our Trust, Transparency, and Our Mission series — covering our story, our legal compliance, our real winners, and how you can verify us. Blog Series Hub: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness Article 1-5 linked here.

    Read more
  3. Research

    Hope on the Horizon: Breakthrough Phase 2 Results for Stargardt Disease Therapy

    A groundbreaking Phase 2 trial has shown the first-ever vision improvements in people with Stargardt disease — a condition with no approved treatment. Nanoscope Therapeutics’ gene-agnostic MCO-010 therapy produced meaningful gains in vision without serious side effects, paving the way for a pivotal Phase 3 trial starting in 2025.

    Read more

All fundraiser stories